NA
ZOM

NewEdge Advisors’s Zomedica Corp. ZOM Stock Holding History

NewEdge Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-60,700
Closed -$7.28K – 4148
2024
Q4 		$7.28K Hold
60,700
– – ﹤0.01% 3123
2024
Q3 		$8.33K Sell
60,700
-288
-0.5% -$40 ﹤0.01% 3000
2024
Q2 		$8.92K Buy
60,988
+35,000
+135% +$5.24K ﹤0.01% 2897
2024
Q1 		$3.79K Hold
25,988
– – ﹤0.01% 3236
2023
Q4 		$3.46K Buy
25,988
+5,200
+25% +$914 ﹤0.01% 3221
2023
Q3 		$3.47K Buy
20,788
+288
+1% +$56 ﹤0.01% 2909
2023
Q2 		$4.1K Hold
20,500
– – ﹤0.01% 2875
2023
Q1 		$4.34K Hold
20,500
– – ﹤0.01% 2826
2022
Q4 		$3.34K Buy
+20,500
New +$4.2K ﹤0.01% 2715

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

NewEdge Advisors's ZOM Position: Q1 2025 in Review

NewEdge Advisors sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 60,700 shares — an estimated $7.28K sold.

NewEdge Advisors first reported a position in ZOM in Q4 2022 and held it in 9 quarters. The position peaked at $8.92K in Q2 2024. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • NewEdge Advisors reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • NewEdge Advisors sold 60,700 Zomedica Corp. shares in Q1 2025, an estimated $7.28K.
  • NewEdge Advisors first reported a position in Zomedica Corp. in Q4 2022 and held it in 9 quarters.
  • NewEdge Advisors's Zomedica Corp. position peaked at $8.92K in Q2 2024.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on NewEdge Advisors's 13F filing for Q1 2025, filed 15 May 2025.